|
Co diagnostics Inc (NASDAQ: CODX) |
|
Co diagnostics Inc
CODX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Co Diagnostics Inc 's sales fell
by -95.57 % in the fourth quarter of 2024 from the same quarter a year ago.
Medical Equipment & Supplies industry recorded
deterioration of revenues by -0.09 %
Co Diagnostics Inc net loss decreased from $-15 millions, to $-11 millions in fourth quarter of 2024,
• More on CODX's Growth
|
|
Co Diagnostics Inc realized a net loss in trailing twelve months.
Co Diagnostics Inc realized cash reduction of $ -0.39 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.25.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.17.
• More on CODX's Valuation
|
|
|
|
|
Co Diagnostics Inc realized net loss in trailing twelve months.
Co Diagnostics Inc realized cash outflow of $ -0.39per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.25.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.17.
Co Diagnostics Inc Price to Book Ratio is at 0.16 higher than Industry Avg. of -507.42, and higher than S&P 500 Avg. of 0.01
• More on CODX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com